arrow
D

Daniel González

Duke University School of Medicine
H指数:33
被引数:3,993

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10‑Monohydroxy Derivative to Inform Dosing in Children with Obesity

更正:奥卡西平及其活性代谢物10-单羟基衍生物的群体药代动力学建模,以指导肥胖儿童用药剂量

2026-01-060
OAAI
Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity

奥卡沙比平及其活性代谢物10-单羟基衍生物的群体药代动力学建模,以指导肥胖儿童的剂量方案

2025-11-170
OAAI
Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening: Insights from a Diverse Population-Based Retrospective Study

Aptima hrHPV核酸扩增与巴氏涂片联合检测在宫颈癌筛查中的性能评价:来自一项多样化人群为基础的回顾性研究的见解

2025-09-230
PRE
Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling Approach

探索肥胖和CYP2C19基因型对兰索拉唑药代动力学的影响:一种群体模型方法

2025-05-160
PRE
Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real-World Data

基于生理学和群体药代动力学模型的肥胖儿童中效唑仑研究:基于真实世界数据

2025-05-130
OA
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Abatacept,Cenicriviroc或英夫利昔单抗治疗COVID-19肺炎住院成人的随机临床试验

2023-07-2535
OA